Improving HPV vaccination rates among adolescents.
TweenVax: A comprehensive practice-, provider-, and parent/patient-level intervention to improve adolescent HPV vaccination.
This study is all about helping more kids aged 11 to 12 get the HPV vaccine by improving how doctors talk about it and teaching parents why it's important, so they can feel more supported in getting their children vaccinated.
Quick facts
| Grant type | R37 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-10799134 on NIH RePORTER |
What this research studies
This research focuses on increasing the rates of HPV vaccination among adolescents aged 11 to 12 years by implementing a comprehensive intervention called TweenVax. The approach involves enhancing communication and recommendations from healthcare providers, as well as educating parents and patients about the importance of the HPV vaccine. By addressing barriers to vaccination through a systems-level strategy, the study aims to create a supportive environment that encourages vaccination. The intervention will be evaluated through a randomized trial to assess its effectiveness in improving vaccination rates.
Who could benefit from this research
Good fit: Ideal candidates for this research are adolescents aged 11 to 12 years who are due for their HPV vaccination.
Not a fit: Patients who have already completed the HPV vaccination series or are older than 13 years may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly increase HPV vaccination rates, thereby reducing the incidence of HPV-related cancers in adolescents.
How similar studies have performed: Previous research has shown that targeted interventions can effectively improve vaccination rates, suggesting that this approach may also yield positive results.
Where this research is happening
Atlanta, United States
- Emory University — Atlanta, United States (Active)
Researchers
- Principal investigator: Bednarczyk, Robert a. — Emory University
- Study coordinator: Bednarczyk, Robert a.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.